The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of INC280 plus erlotinib in patients with MET expressing adenocarcinoma of the lung.
 
Caroline Elizabeth McCoach
No Relationships to Disclose
 
Aiming Yu
Patents, Royalties, Other Intellectual Property - US application seriol no. 02/003,806 International patent PCT/US2013/021307 (Inst)
 
David R. Gandara
Honoraria - Array BioPharma; AstraZeneca; Celgene; Lilly; Novartis; Synta
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Pfizer; Response Genetics; Sanofi; Synta
Research Funding - Abbott Laboratories (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); ImClone Systems (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Biomarin; Boehringer Ingelheim; Dava Oncology; Pfizer
 
Jonathan Riess
Honoraria - Roche/Genentech
Research Funding - Millennium; Onconova Therapeutics
Travel, Accommodations, Expenses - Roche/Genentech
 
Tianhong Li
Speakers' Bureau - Pfizer
Research Funding - Astellas Pharma (Inst); Lilly (Inst); Novartis (Inst)
 
Primo Lara
Honoraria - Pfizer
Consulting or Advisory Role - Astex Pharmaceuticals; Clovis Oncology; Exelixis; Halozyme; Immunogen; Janssen; Lilly; LPath; Medivation; Novartis; Pfizer; Sanofi; Teva; US Diagnostic Services
Research Funding - Aragon Pharmaceuticals (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Janssen Biotech (Inst); Millennium (Inst); Oncogenex (Inst); Polaris (Inst)
 
Philip C. Mack
Research Funding - Boehringer Ingelheim; MolecularMD
 
Laurel Beckett
Honoraria - Roche Pharma AG
 
Eric Daniel Slosberg
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
 
Karen Kelly
Consulting or Advisory Role - Boehringer Ingelheim; Clovis Oncology; Daiichi Sankyo; Genentech; Lilly; Synta; Transgene
Research Funding - EMD Serono; Genentech; Lilly; Millennium; Novartis; Proacta
Patents, Royalties, Other Intellectual Property - UpToDate